A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men

CONTEXT: A novel formulation of oral testosterone (T) undecanoate (TU) was evaluated in a phase 3 clinical trial. OBJECTIVE: Determine efficacy, short-term safety, and alignment of new oral TU formulation with current US approval standards for T replacement therapy. DESIGN: Randomized, active-contro...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Endocrinol Metab
Главные авторы: Swerdloff, Ronald S, Wang, Christina, White, William B, Kaminetsky, Jed, Gittelman, Marc C, Longstreth, James A, Dudley, Robert E, Danoff, Theodore M
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Clinical Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7282712/
https://ncbi.nlm.nih.gov/pubmed/32382745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa238
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы